{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:22:20Z","timestamp":1793319740163,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011033","name":"Thermo Fisher Scientific","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011033","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Programme Hospitalier de Recherche Clinique, French Ministry of Health"},{"DOI":"10.13039\/501100022110","name":"bioM\u00e9rieux","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Treating pneumonia in old patients remains challenging for clinicians. Moreover, bacterial antimicrobial resistance is a major public health threat.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>The PROPAGE study evaluated the interest of a strategy using serial measurements of procalcitonin (PCT) to reduce the duration of antibiotic therapy in old patients with pneumonia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>PROPAGE took place from Dec.-2013 to Jun.-2016 in eight French geriatric units. It was a prospective, comparative, randomised, open-label study involving old patients (\u2265\u200980 years) who had initiated antibiotic treatment for pneumonia in the previous 48\u00a0h. PCT was monitored in all patients and two decision-making PCT-based algorithms guided antibiotic therapy in patients from the PCT group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>107 patients were randomised (PCT, <jats:italic>n<\/jats:italic>\u2009=\u200950; Control, <jats:italic>n<\/jats:italic>\u2009=\u200957). Antibiotic therapy exposure was reduced in the PCT group as compared to the Control group (median duration of antibiotic therapy, 8 vs. 10 days [rank-test, <jats:italic>p<\/jats:italic>\u2009=\u20090.001]; antibiotic persistence rates on Days 6 and 8, 54% and 44% vs. 91% and 72%) and no significant difference was found in recovery rate (84% vs. 89.5%; Pearson Chi\u00b2 test, <jats:italic>p<\/jats:italic>\u2009=\u20090.402).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Although, the superiority of the strategy was not tested using a composite criterion combining antibiotic therapy duration and recovery rate was not tested due to the small sample size, the present study showed that monitoring associated with PCT-guided algorithm could help shorten antibiotic treatment duration in the very old patients without detrimental effects. Measuring PCT levels between Day 4 and Day 6 could be helpful when making the decision regarding antibiotic discontinuation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>NCT02173613. This study was first registered on 25\/06\/2014.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12877-022-03658-4","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T08:03:09Z","timestamp":1671004989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Procalcitonin to reduce exposure to antibiotics and individualise treatment in hospitalised old patients with pneumonia: a randomised study"],"prefix":"10.1186","volume":"22","author":[{"given":"Ga\u00ebtan","family":"Gavazzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Drevet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Debray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Luc","family":"Bosson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatah","family":"Tidadini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Paccalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"de Wazieres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Celarier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bonnefoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Vitrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,14]]},"reference":[{"key":"3658_CR1","doi-asserted-by":"publisher","first-page":"570-6","DOI":"10.1093\/infdis\/jiz053","volume":"222","author":"T Shi","year":"2020","unstructured":"Shi T, Denouel A, Tietjen A, et al. Global and regional burden of hospital admissions for pneumonia in older adults: a systematic review and meta-analysis. J Infect Dis. 2020;222:570-6.","journal-title":"J Infect Dis"},{"key":"3658_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.rmed.2018.02.007","volume":"137","author":"A Torres","year":"2018","unstructured":"Torres A, Cill\u00f3niz C, Blasi F, et al. Burden of pneumococcal community-acquired pneumonia in adults across Europe: a literature review. Respir Med. 2018;137:6\u201313.","journal-title":"Respir Med"},{"key":"3658_CR3","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","volume":"18","author":"C Troeger","year":"2018","unstructured":"Troeger C, Blacker B, Khalil I, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990\u20132016: a systematic analysis for the global burden of Disease Study 2016. Lancet Infect Dis. 2018;18:1191\u2013210.","journal-title":"Lancet Infect Dis"},{"key":"3658_CR4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S1473-3099(02)00437-1","volume":"2","author":"G Gavazzi","year":"2002","unstructured":"Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis. 2002;2:659\u201366.","journal-title":"Lancet Infect Dis"},{"key":"3658_CR5","doi-asserted-by":"publisher","first-page":"133-vii","DOI":"10.1016\/S0025-7125(05)70308-4","volume":"85","author":"S Rajagopalan","year":"2001","unstructured":"Rajagopalan S, Yoshikawa T. Antimicrobial therapy in the elderly. Med Clin North Am. 2001;85:133-vii.","journal-title":"Med Clin North Am"},{"key":"3658_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cmi.2014.08.018","volume":"21","author":"C Beckett","year":"2015","unstructured":"Beckett C, Harbarth S, Huttner B. Special considerations of antibiotic prescription in the geriatric population. Clin Microbiol Infect. 2015;21:3\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"3658_CR7","doi-asserted-by":"publisher","first-page":"e893","DOI":"10.1016\/S2542-5196(21)00280-1","volume":"5","author":"A Browne","year":"2021","unstructured":"Browne A, Chipeta M, Haines-Woodhouse G, et al. Global antibiotic consumption and usage in humans, 2000\u201318: a spatial modelling study. Lancet Planet Health. 2021;5:e893\u2013904.","journal-title":"Lancet Planet Health"},{"key":"3658_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.7326\/M18-3640","volume":"171","author":"V Vaughn","year":"2019","unstructured":"Vaughn V, Flanders S, Snyder A, et al. Excess antibiotic treatment duration and adverse events in patients hospitalized with pneumonia: a multihospital cohort study. Ann Intern Med. 2019;171:153\u201363.","journal-title":"Ann Intern Med"},{"key":"3658_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"C Murray","year":"2022","unstructured":"Murray C, Ikuta K, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629\u201355.","journal-title":"Lancet"},{"key":"3658_CR10","doi-asserted-by":"publisher","first-page":"ofaa452","DOI":"10.1093\/ofid\/ofaa452","volume":"7","author":"J Carlet","year":"2020","unstructured":"Carlet J, Jarlier V, Acar J, et al. Trends in Antibiotic Consumption and Resistance in France over 20 years: large and continuous efforts but contrasting results. Open Forum Infect Dis. 2020;7:ofaa452.","journal-title":"Open Forum Infect Dis"},{"key":"3658_CR11","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"J Metlay","year":"2019","unstructured":"Metlay J, Waterer G, Long A, et al. Diagnosis and treatment of adults with community-acquired Pneumonia. An Official Clinical Practice Guideline of the american thoracic society and infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200:e45\u201367.","journal-title":"Am J Respir Crit Care Med"},{"key":"3658_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1183\/09031936.00130909","volume":"36","author":"S Aliberti","year":"2010","unstructured":"Aliberti S, Blasi F, Zanaboni A, et al. Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia. Eur Respir J. 2010;36:128\u201334.","journal-title":"Eur Respir J"},{"key":"3658_CR13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/cpt.2194","volume":"110","author":"L Aulin","year":"2021","unstructured":"Aulin L, de Lange D, Saleh M, et al. Biomarker-guided individualization of antibiotic therapy. Clin Pharmacol Ther. 2021;110:346\u201360.","journal-title":"Clin Pharmacol Ther"},{"key":"3658_CR14","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1183\/09031936.00053209","volume":"34","author":"D Stolz","year":"2009","unstructured":"Stolz D, Smyrnios N, Eggimann P, et al. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. Eur Respir J. 2009;34:1364\u201375.","journal-title":"Eur Respir J"},{"key":"3658_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","volume":"18","author":"P Schuetz","year":"2018","unstructured":"Schuetz P, Wirz Y, Sager R, et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018;18:95\u2013107.","journal-title":"Lancet Infect Dis"},{"key":"3658_CR16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","volume":"375","author":"L Bouadma","year":"2010","unstructured":"Bouadma L, Luyt C, Tubach F, et al. Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010;375:463\u201374.","journal-title":"Lancet"},{"key":"3658_CR17","first-page":"CD007498","volume":"10","author":"P Schuetz","year":"2017","unstructured":"Schuetz P, Wirz Y, Sager R, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2017;10:CD007498.","journal-title":"Cochrane Database Syst Rev"},{"key":"3658_CR18","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","volume":"16","author":"E de Jong","year":"2016","unstructured":"de Jong E, van Oers J, Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016;16:819\u201327.","journal-title":"Lancet Infect Dis"},{"key":"3658_CR19","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1186\/cc7903","volume":"13","author":"M Hochreiter","year":"2009","unstructured":"Hochreiter M, K\u00f6hler T, Schweiger A, et al. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care. 2009;13:R83.","journal-title":"Crit Care"},{"key":"3658_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.7754\/Clin.Lab.2013.130125","volume":"60","author":"L Yan","year":"2014","unstructured":"Yan L, Liao P, Xu L, et al. Usefulness of procalcitonin in elderly patients with bacterial infection. Clin Lab. 2014;60:139\u201342.","journal-title":"Clin Lab"},{"key":"3658_CR21","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1111\/ijcp.12278","volume":"67","author":"S Lee","year":"2013","unstructured":"Lee S, Chan R, Wu J, et al. Diagnostic value of procalcitonin for bacterial infection in elderly patients \u2013 a systemic review and meta-analysis. Int J Clin Pract. 2013;67:1350\u201357.","journal-title":"Int J Clin Pract"},{"key":"3658_CR22","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1111\/j.1532-5415.2005.53421.x","volume":"53","author":"F Stucker","year":"2005","unstructured":"Stucker F, Herrmann F, Graf J, et al. Procalcitonin and infection in elderly patients. J Am Geriatr Soc. 2005;53:1392\u201395.","journal-title":"J Am Geriatr Soc"},{"key":"3658_CR23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ejim.2005.08.001","volume":"16","author":"HU Rehman","year":"2005","unstructured":"Rehman HU. Under-representation of the elderly in clinical trials. Eur J Intern Med. 2005;16:385\u201386.","journal-title":"Eur J Intern Med"},{"key":"3658_CR24","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1186\/s12877-020-01954-5","volume":"20","author":"V Prendki","year":"2020","unstructured":"Prendki V, Tau N, Avni T, et al. A systematic review assessing the under-representation of elderly adults in COVID-19 trials. BMC Geriatr. 2020;20:538.","journal-title":"BMC Geriatr"},{"key":"3658_CR25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ijcard.2017.01.018","volume":"232","author":"C Vitale","year":"2017","unstructured":"Vitale C, Fini M, Spoletini I, et al. Under-representation of elderly and women in clinical trials. Int J Cardiol. 2017;232:216\u201321.","journal-title":"Int J Cardiol"},{"key":"3658_CR26","doi-asserted-by":"crossref","unstructured":"Soci\u00e9t\u00e9 de pathologie infectieuse de langue fran\u00e7aise. Xve conf\u00e9rence de consensus en th\u00e9rapeutique anti-infectieuse. Prise en charge des infections des voies respiratoires basses de l\u2019adulte immunocomp\u00e9tent [15th consensus conference about management of lower respiratory tract infections in immunocompetent adult]. Med Mal Infect. 2006;36 :235 \u2013 44.","DOI":"10.1016\/j.medmal.2006.04.003"},{"key":"3658_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000062967","volume":"1","author":"Y Guigoz","year":"1999","unstructured":"Guigoz Y, Vellas B. The Mini Nutritional Assessment (MNA) for grading the nutritional state of elderly patients: presentation of the MNA, history and validation. Nestle Nutr Workshop Ser Clin Perform Programme. 1999;1:3\u201311.","journal-title":"Nestle Nutr Workshop Ser Clin Perform Programme"},{"key":"3658_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/geront\/10.1_Part_1.20","volume":"10","author":"S Katz","year":"1970","unstructured":"Katz S, Downs TD, Cash HR, et al. Progress in development of the index of ADL. Gerontologist. 1970;10:20\u201330.","journal-title":"Gerontologist"},{"key":"3658_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","volume":"9","author":"MP Lawton","year":"1969","unstructured":"Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179\u201386.","journal-title":"Gerontologist"},{"key":"3658_CR30","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"W Knaus","year":"1985","unstructured":"Knaus W, Draper E, Wagner D, et al. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818\u201329.","journal-title":"Crit Care Med"},{"key":"3658_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJM199701233360402","volume":"336","author":"M Fine","year":"1997","unstructured":"Fine M, Auble T, Yealy D, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243\u201350.","journal-title":"N Engl J Med"},{"key":"3658_CR32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/thorax.58.5.377","volume":"58","author":"W Lim","year":"2003","unstructured":"Lim W, van der Eerden M, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58:377\u201382.","journal-title":"Thorax"},{"key":"3658_CR33","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1093\/ageing\/afab078","volume":"50","author":"E Heilmann","year":"2021","unstructured":"Heilmann E, Gregoriano C, Annane D, et al. Duration of antibiotic treatment using procalcitonin-guided treatment algorithms in older patients: a patient-level meta-analysis from randomized controlled trials. Age Ageing. 2021;50:1546\u201356.","journal-title":"Age Ageing"},{"key":"3658_CR34","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/jama.2009.1297","volume":"302","author":"P Schuetz","year":"2009","unstructured":"Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procalcitonin-based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract Infections: the ProHOSP Randomized Controlled Trial. JAMA. 2009;302:1059\u201366.","journal-title":"JAMA"},{"key":"3658_CR35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.pupt.2017.06.008","volume":"45","author":"S Aliberti","year":"2017","unstructured":"Aliberti S, Ramirez J, Giuliani F, et al. Individualizing duration of antibiotic therapy in community-acquired pneumonia. Pulm Pharmacol Ther. 2017;45:191\u2013201.","journal-title":"Pulm Pharmacol Ther"},{"key":"3658_CR36","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s11739-017-1627-7","volume":"12","author":"F Pieralli","year":"2017","unstructured":"Pieralli F, Corbo L, Torrigiani A, et al. Usefulness of procalcitonin in differentiating Candida and bacterial blood stream infections in critically ill septic patients outside the intensive care unit. Intern Emerg Med. 2017;12:629\u201335.","journal-title":"Intern Emerg Med"},{"key":"3658_CR37","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/archinternmed.2012.770","volume":"172","author":"W Albrich","year":"2012","unstructured":"Albrich W, Dusemund F, Bucher B, et al. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in \u201creal life\u201d: an international, multicenter poststudy survey (ProREAL). Arch Intern Med. 2012;172:715\u201322.","journal-title":"Arch Intern Med"},{"key":"3658_CR38","doi-asserted-by":"publisher","unstructured":"Tiseo G, Suardi LR, Giusti L, et al. Predictors and outcomes of respiratory bacterial coinfections in patients with COVID-19 admitted to hospital: An observational prospective study. Respirology. 2022. doi:https:\/\/doi.org\/10.1111\/resp.14372","DOI":"10.1111\/resp.14372"},{"key":"3658_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ijid.2022.03.003","volume":"118","author":"E Moreno-Garc\u00eda","year":"2022","unstructured":"Moreno-Garc\u00eda E, Puerta-Alcalde P, Letona L, et al. Bacterial co-infection at hospital admission in patients with COVID-19. Int J Infect Dis. 2022;118:197\u2013202.","journal-title":"Int J Infect Dis"}],"updated-by":[{"DOI":"10.1186\/s12877-023-03818-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000}}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-022-03658-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-022-03658-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-022-03658-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T12:08:39Z","timestamp":1680178119000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-022-03658-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,14]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3658"],"URL":"https:\/\/doi.org\/10.1186\/s12877-022-03658-4","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12877-023-03818-0","asserted-by":"object"}]},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,14]]},"assertion":[{"value":"9 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12877-023-03818-0","URL":"https:\/\/doi.org\/10.1186\/s12877-023-03818-0","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PROPAGE was conducted in compliance with the International Conference on Harmonisation-Good Clinical Practice Guidelines and the applicable regulatory requirements. The protocol was authorised by the Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament on 19 September 2011 and approved by the <i>Comit\u00e9 de Protection des Personnes Sud Est V<\/i> (Independent Ethics Committee) of the teaching hospital of Grenoble on 05 October 2011 (approval n\u00b02011-A01026-35). Written informed consent for participation in the study was obtained from all candidates or from their legal representatives.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GG has received consulting fees from Thermo Fischer Scientific. Other co-authors report no conflicts of interest relevant to this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"965"}}